Characteristics | ||
---|---|---|
Age (years) | Mean±SD | 65.6±14.3 |
Median | 67.7 | |
Range | 19.4–95.9 | |
Gender | ||
Male | % (n/N) | 52.7% (154/292) |
Female | % (n/N) | 47.3% (138/292) |
Race/ethnicity | ||
American Indian/Alaska Native | % (n/N) | 0.0% (0/292) |
Asian | % (n/N) | 1.0% (3/292) |
Black or African American | % (n/N) | 14.4% (42/292) |
Hispanic or Latino | % (n/N) | 6.2% (18/292) |
Native Hawaiian/Pacific Islander | % (n/N) | 0.0% (0/292) |
White | % (n/N) | 79.1% (231/292) |
Time from symptom onset to baseline (h) | Mean±SD | 7.7±2.8 |
Median | 7.3 | |
Range | 1.8–13.8 | |
Baseline NIHSS | n | 292 |
Mean±SD | 10.6±4.2 | |
Median | 10.0 | |
Range | 2.0–19.0 | |
Side of infarct | ||
Right | % (n/N) | 43.6% (123/282) |
Left | % (n/N) | 56.4% (159/282) |
Medical history | N=292 | |
General history | ||
Diabetes mellitus | % (n/N) | 21.2% (62/292) |
Insulin-dependent diabetes | % (n/N) | 7.5% (22/292) |
Non-insulin dependent diabetes | % (n/N) | 13.7% (40/292) |
Diabetes mellitus or new diagnosis within 30 days of enrollment | % (n/N) | 32.5% (95/292) |
Hypertension | % (n/N) | 71.2% (208/292) |
Hypertension or new diagnosis within 30 days of enrollment | % (n/N) | 79.1% (231/292) |
Hyperlipidemia | % (n/N) | 52.1% (152/292) |
Current smoker | % (n/N) | 28.8% (84/292) |
Neurological history | ||
Cerebral ischemic infarct (stroke) | % (n/N) | 15.8% (46/292) |
Transient ischemic attack | % (n/N) | 11.3% (33/292) |
Seizure | % (n/N) | 3.4% (10/292) |
Cardiovascular history | ||
Atrial fibrillation | % (n/N) | 23.3% (68/292) |
Atrial fibrillation or new diagnosis within 30 days of enrollment | % (n/N) | 28.4% (83/292) |
Valvular disease/replacement | % (n/N) | 6.2% (18/292) |
Peripheral vascular disease | % (n/N) | 5.5% (16/292) |
Percutaneous transluminal coronary angioplasty | % (n/N) | 9.2% (27/292) |
Coronary artery bypass graft | % (n/N) | 10.6% (31/292) |
Myocardial infarction | % (n/N) | 12.0% (35/292) |
Angina | % (n/N) | 8.2% (24/292) |
NIHSS, National Institutes of Health Stroke Scores.